Abstract
Uveal melanoma is the most common cancer of the eye in which approximately 50 % of cases develop metastases that are fatal within 2–15 years. Thus it is critical to identify prognostic markers to select high-risk patients into an adjuvant treatment. Chromosomal copy number alterations have been associated with poor prognosis. Historically the gold standard for identifying chromosomal aberrations had been fluorescent in situ hybridization. But in recent years other techniques have been developed that allow very rapid molecular analysis for estimation of chromosomal copy number with finer resolution. These include microsatellite analysis, multiple ligation-dependent probe amplification, and, most recently, genome-wide single-nucleotide polymorphism array analysis. These various procedures have identified loss of all or part of chromosome 3 (monosomy), losses of 1p, 6q, or 8p, or gains of 6p or 8q which, together with tumor location, morphology, and size, can be used to accurately predict the risk of metastasis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Gaudi SM JL (2011) Molecular bases of cutaneous and uveal melanomas. Pathol Res Int. doi: 10.4061/2011/159421
van den Bosch T, Kilic E, Paridaens D, de Klein A (2010) Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract. doi:10.1155/2010/360136
Damato B (2004) Developments in the management of uveal melanoma. Clin Exp Ophthalmol 32:639–647
Shields J, Shields CL (2008) Posterior uveal melanoma. Clinical features. Lippincott, Williams and Wilkins, Philadelphia, PA
Kujala E, Mäkitie T, Kivelä T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44:4651–4659
Paul EV, Parnell BL, Fraker M (1962) Prognosis of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin 12:387–402
Kincaid MC (1998) Uveal melanoma. Cancer Control 5:299–309
Damato B, Coupland SE (2009) A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye 23:2152–2162
Damato B, Eleuteri A, Taktak AFG, Coupland SE (2011) Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 30:285–295
Prescher G, Bornfeld N, Becher R (1990) Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst 82:1765–1769
Sisley K, Cottam DW, Rennie IG, Parsons MA, Potter AM, Potter CW et al (1992) Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 5:197–200
Sisley KR, Rennie IG, Cottam DW, Potter AM, Potter CW, Rees RC (1990) Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 2:205–209
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347:1222–1225
Damato B, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland SE (2009) Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 50:3048–3055
Damato B, Dopierala JA, Coupland SE (2010) Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 16:6083–6092
Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I et al (2007) Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 114:1925–1931
Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM et al (2005) Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 46:2253–2257
van den Bosch T, van Beek JGM, Vaarwater J, Verdijk RM, Naus NC, Paridaens D et al (2012) Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Invest Ophthalmol Vis Sci 53:2668–2674
Cross NA, Ganesh A, Parpia M, Murray AK, Rennie IG, Sisley K (2006) Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye 20:476–481
Parrella P, Fazio VM, Gallo AP, Sidransky D, Merbs SL (2003) Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res 63:8507–8510
Tschentscher F, Prescher G, Horsman DE, White VA, Rieder H, Anastassiou G et al (2001) Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res 61:3439–3442
Naus NC, Verhoeven ACA, van Drunen E, Slater R, Mooy CM, Paridaens DA et al (2002) Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res 8:534–539
Aronow M, Sun Y, Saunthararajah Y, Biscotti C, Tubbs R, Triozzi P et al (2012) Monosomy 3 by FISH in uveal melanoma: variability in techniques and results. Surv Ophthalmol 57:463–473
Lake SL, Damato BE, Dopierala J, Baudo MM, Taktak AFG, Coupland SE (2011) Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities. Invest Ophthalmol Vis Sci 52:5559–5564
Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC et al (2012) Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Melanoma Res 22:30–37
Lake SL, Coupland SE, Taktak AFG, Damato BE (2010) Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci 51:4884–4891
Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR (2000) Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 122:13–17
Shields CL, Ganguly A, Materin MA, Teixeira L, Mashayekhi A, Swanson LA et al (2007) Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Arch Ophthalmol 125:1017–1024
Ewens KG, Kanetsky PA, Richards-Yutz J, Al-Dahmash S, De Luca, MC, Bianciotto CG et al (2013) Genomic profile of 320 uveal melanoma cases: Chromosome 8p-loss and metastatic outcome. Invest Ophthalmol Vis Sci 54:5721–5729
Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C (2004) dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20:1233–1240
Genome-Wide Human SNP Nsp/Sty 6.0 User Guide. http://www.affymetrix.com/support/technical/byproduct.affx?product=genomewidesnp_nsp_sty_assay
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Ganguly, A., Richards-Yutz, J., Ewens, K.G. (2014). Molecular Karyotyping for Detection of Prognostic Markers in Fine Needle Aspiration Biopsy Samples of Uveal Melanoma. In: Thurin, M., Marincola, F. (eds) Molecular Diagnostics for Melanoma. Methods in Molecular Biology, vol 1102. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-727-3_23
Download citation
DOI: https://doi.org/10.1007/978-1-62703-727-3_23
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-726-6
Online ISBN: 978-1-62703-727-3
eBook Packages: Springer Protocols